AAAAAA

   
Results: 1-25 | 26-46 |
Results: 26-46/46
TOPOTECAN, AN ACTIVE-DRUG IN THE 2ND-LINE TREATMENT OF EPITHELIAL OVARIAN-CANCER - RESULTS OF A LARGE EUROPEAN PHASE-II STUDY
Authors: CREEMERS GJ BOLIS G GORE M SCARFONE G LACAVE AJ GUASTALLA JP DESPAX R FAVALLI G KREINBERG R VANBELLE S HUDSON I VERWEIJ J HUININK WWT
Citation: Gj. Creemers et al., TOPOTECAN, AN ACTIVE-DRUG IN THE 2ND-LINE TREATMENT OF EPITHELIAL OVARIAN-CANCER - RESULTS OF A LARGE EUROPEAN PHASE-II STUDY, Journal of clinical oncology, 14(12), 1996, pp. 3056-3061
STRUCTURAL EVOLUTION OF THE EASTERN BALKANS (BULGARIA)
Authors: DOGLIONI C BUSATTA C BOLIS G MARIANINI L ZANELLA M
Citation: C. Doglioni et al., STRUCTURAL EVOLUTION OF THE EASTERN BALKANS (BULGARIA), Marine and petroleum geology, 13(2), 1996, pp. 225-251
DETERMINANTS OF RESPONSE TO A CISPLATIN-BASED REGIMEN AS NEOADJUVANT CHEMOTHERAPY IN STAGE IB-IIB INVASIVE CERVICAL-CANCER
Authors: BOLIS G VANZAINTENPRZYBYSZ I SCARFONE G ZANABONI F SCARABELLI C TATEO S CALABRESE M PARAZZINI F
Citation: G. Bolis et al., DETERMINANTS OF RESPONSE TO A CISPLATIN-BASED REGIMEN AS NEOADJUVANT CHEMOTHERAPY IN STAGE IB-IIB INVASIVE CERVICAL-CANCER, Gynecologic oncology, 63(1), 1996, pp. 62-65
UNTITLED
Authors: BOLIS G VILLA A GUARNERIO P ACERBONI S PARAZZINI F
Citation: G. Bolis et al., UNTITLED, Gynecologic oncology, 61(1), 1996, pp. 156-157
SURVIVAL OF WOMEN WITH ADVANCED OVARIAN-CANCER AND COMPLETE PATHOLOGICAL RESPONSE AT 2ND-LOOK LAPAROTOMY
Authors: BOLIS G VILLA A GUARNERIO P FERRARIS C GAVONI N GIARDINA G MELPIGNANO M SCARFONE G ZANABONI F PARAZZINI F
Citation: G. Bolis et al., SURVIVAL OF WOMEN WITH ADVANCED OVARIAN-CANCER AND COMPLETE PATHOLOGICAL RESPONSE AT 2ND-LOOK LAPAROTOMY, Cancer, 77(1), 1996, pp. 128-131
THE KUSTNER TECHNIQUE - A NEGLECTED TRANSVERSE LOWER ABDOMINAL INCISION
Authors: VERCELLINI P BOLIS G CROSIGNANI PG
Citation: P. Vercellini et al., THE KUSTNER TECHNIQUE - A NEGLECTED TRANSVERSE LOWER ABDOMINAL INCISION, American journal of obstetrics and gynecology, 174(4), 1996, pp. 1394-1394
REGRESSION OF ADVANCED OVARIAN-CARCINOMA BY INTRAPERITONEAL TREATMENTWITH AUTOLOGOUS T-LYMPHOCYTES RETARGETED BY A BISPECIFIC MONOCLONAL-ANTIBODY
Authors: CANEVARI S STOTER G ARIENTI F BOLIS G COLNAGHI MI DIRE EM EGGERMONT AMM GOEY SH GRATAMA JW LAMERS CHJ NOOY MA PARMIANI G RASPAGLIESI F RAVAGNANI F SCARFONE G TRIMBOS JB WARNAAR SO BOLHUIS RLH
Citation: S. Canevari et al., REGRESSION OF ADVANCED OVARIAN-CARCINOMA BY INTRAPERITONEAL TREATMENTWITH AUTOLOGOUS T-LYMPHOCYTES RETARGETED BY A BISPECIFIC MONOCLONAL-ANTIBODY, Journal of the National Cancer Institute, 87(19), 1995, pp. 1463-1469
ERGOLINE DERIVATES AS A PROBE FOR FEATURING THE 5-HT1A RECEPTOR PHARMACOPHORE
Authors: BOLIS G PILLAN A MANTEGANI S BRAMBILLA E DOLMELLA A
Citation: G. Bolis et al., ERGOLINE DERIVATES AS A PROBE FOR FEATURING THE 5-HT1A RECEPTOR PHARMACOPHORE, JOURNAL OF MOLECULAR MODELING, 1(4), 1995, pp. 188-195
SURVIVAL OF ADVANCED OVARIAN-CANCER PATIENTS WITH MICROSCOPIC PARTIAL-RESPONSE AFTER SURGERY AND FIRST-LINE CHEMOTHERAPY
Authors: BOLIS G VILLA A FERRARIS C LUCHINI L PARAZZINI F
Citation: G. Bolis et al., SURVIVAL OF ADVANCED OVARIAN-CANCER PATIENTS WITH MICROSCOPIC PARTIAL-RESPONSE AFTER SURGERY AND FIRST-LINE CHEMOTHERAPY, European journal of cancer, 31A(6), 1995, pp. 1019-1020
SINGLE-DOSE INTRAPERITONEAL RADIOIMMUNOTHERAPY WITH THE MURINE MONOCLONAL-ANTIBODY I-131 MOV18 - CLINICAL-RESULTS IN PATIENTS WITH MINIMAL RESIDUAL DISEASE OF OVARIAN-CANCER
Authors: CRIPPA F BOLIS G SEREGNI E GAVONI N SCARFONE G FERRARIS C BURAGGI GL BOMBARDIERI E
Citation: F. Crippa et al., SINGLE-DOSE INTRAPERITONEAL RADIOIMMUNOTHERAPY WITH THE MURINE MONOCLONAL-ANTIBODY I-131 MOV18 - CLINICAL-RESULTS IN PATIENTS WITH MINIMAL RESIDUAL DISEASE OF OVARIAN-CANCER, European journal of cancer, 31A(5), 1995, pp. 686-690
CLINICAL-RESULTS OF A NEW APPROACH OF THERAPY OF OVARIAN-CANCER - RETARGETING OF T-CELL CYTOTOXICITY BY BISPECIFIC ANTIBODIES
Authors: CANEVARI S MAZZONI A NEGRI DRM ARIENTI F RAMAKRISHNA V BOLHUIS R BOLIS G COLNAGHI MI
Citation: S. Canevari et al., CLINICAL-RESULTS OF A NEW APPROACH OF THERAPY OF OVARIAN-CANCER - RETARGETING OF T-CELL CYTOTOXICITY BY BISPECIFIC ANTIBODIES, European journal of cancer, 31A, 1995, pp. 493-493
ADJUVANT TREATMENT FOR EARLY EPITHELIAL OVARIAN-CANCER - RESULTS OF 2RANDOMIZED CLINICAL-TRIALS COMPARING CISPLATIN TO NO FURTHER TREATMENT OR CHROMIC PHOSPHATE (P-32)
Authors: BOLIS G COLOMBO N PECORELLI S TORRI V MARSONI S BONAZZI C CHIARI S FAVALLI G MANGILI C PRESTI M ZANABONI F MANGIONI C
Citation: G. Bolis et al., ADJUVANT TREATMENT FOR EARLY EPITHELIAL OVARIAN-CANCER - RESULTS OF 2RANDOMIZED CLINICAL-TRIALS COMPARING CISPLATIN TO NO FURTHER TREATMENT OR CHROMIC PHOSPHATE (P-32), Annals of oncology, 6(9), 1995, pp. 887-893
SOLUTION STRUCTURE OF A NOVEL HIRUDIN VARIANT HM2, ITS FRAGMENT 1-47 AND THE MUTANT (N64-]V- A NMR AND MD STUDY(G65) )
Authors: TATO M BAUMER L NICASTRO G BOLIS G
Citation: M. Tato et al., SOLUTION STRUCTURE OF A NOVEL HIRUDIN VARIANT HM2, ITS FRAGMENT 1-47 AND THE MUTANT (N64-]V- A NMR AND MD STUDY(G65) ), Journal of cellular biochemistry, 1995, pp. 38-38
CHEMICAL AND ENZYMATIC TREATMENT OF ENDOTHELIN
Authors: PEREGO R GOZZINI L ARLANDINI E BOLIS G DECASTIGLIONE R
Citation: R. Perego et al., CHEMICAL AND ENZYMATIC TREATMENT OF ENDOTHELIN, International journal of peptide & protein research, 46(5), 1995, pp. 341-345
PILOT-STUDY WITH FIXED-DOSE CARBOPLATIN AND ESCALATING PACLITAXEL IN ADVANCED OVARIAN-CANCER
Authors: BOLIS G
Citation: G. Bolis, PILOT-STUDY WITH FIXED-DOSE CARBOPLATIN AND ESCALATING PACLITAXEL IN ADVANCED OVARIAN-CANCER, Seminars in oncology, 22(6), 1995, pp. 32-34
RESPONSE TO 2ND-LINE WEEKLY CISPLATIN CHEMOTHERAPY IN OVARIAN-CANCER PREVIOUSLY TREATED WITH A CISPLATIN-BASED OR CARBOPLATIN-BASED REGIMEN
Authors: BOLIS G SCARFONE G LUCHINI L FERRARIS C ZANABONI F PRESTI M GIARDINA G VILLA A PARAZZINI F
Citation: G. Bolis et al., RESPONSE TO 2ND-LINE WEEKLY CISPLATIN CHEMOTHERAPY IN OVARIAN-CANCER PREVIOUSLY TREATED WITH A CISPLATIN-BASED OR CARBOPLATIN-BASED REGIMEN, European journal of cancer, 30A(12), 1994, pp. 1764-1768
TERTIARY STRUCTURE OF ENDOTHELIN-1 IN WATER BY H-1-NMR AND MOLECULAR-DYNAMICS STUDIES
Authors: RAGG E MONDELLI R PENCO S BOLIS G BAUMER L GUARAGNA A
Citation: E. Ragg et al., TERTIARY STRUCTURE OF ENDOTHELIN-1 IN WATER BY H-1-NMR AND MOLECULAR-DYNAMICS STUDIES, Perkin transactions. 2, (6), 1994, pp. 1317-1326
HIGH-DOSE INTENSITY REGIMENS WITH EPIRUBICIN IN OVARIAN-CANCER
Authors: VERMORKEN JB BOLIS G VANRIJSWIJK REN KOBIERSKA A CHEVALLIER B VANDERBURG MEL ZANABONI F LENTZ MA BURGER CW KENEMANS P PINEDO HM
Citation: Jb. Vermorken et al., HIGH-DOSE INTENSITY REGIMENS WITH EPIRUBICIN IN OVARIAN-CANCER, Seminars in oncology, 21(1), 1994, pp. 17-22
CARCINOMA OF THE CERVIX - VALUE OF PLAIN AND GADOLINIUM-ENHANCED MR-IMAGING IN ASSESSING DEGREE OF INVASIVENESS
Authors: SIRONI S DECOBELLI F SCARFONE G COLOMBO E BOLIS G FERRARI A DELMASCHIO A
Citation: S. Sironi et al., CARCINOMA OF THE CERVIX - VALUE OF PLAIN AND GADOLINIUM-ENHANCED MR-IMAGING IN ASSESSING DEGREE OF INVASIVENESS, Radiology, 188(3), 1993, pp. 797-801
MULTIFOCAL ENDOMETRIOSIS - A CASE-REPORT
Authors: VERCELLINI P VENDOLA N PRESTI M BOLIS G
Citation: P. Vercellini et al., MULTIFOCAL ENDOMETRIOSIS - A CASE-REPORT, Journal of reproductive medicine, 38(10), 1993, pp. 815-819
ENDOMETRIOSIS AND OVARIAN-CANCER
Authors: VERCELLINI P PARAZZINI F BOLIS G CARINELLI S DINDELLI M VENDOLA N LUCHINI L CROSIGNANI PG
Citation: P. Vercellini et al., ENDOMETRIOSIS AND OVARIAN-CANCER, American journal of obstetrics and gynecology, 169(1), 1993, pp. 181-182
Risultati: 1-25 | 26-46 |